The PreOncology Platform is built on data from the world’s leading cancer research institutions and governed by clinical standards designed to meet the demands of medical-grade oncology. This fact sheet goes behind the platform to show the data sources, evaluation criteria, and clinical governance that make PreOncology’s approach distinct.
Specifically, you will learn:
- How the Dynamic Risk Engine is trained on data from institutions including the NIH, MD Anderson, Harvard T.H. Chan School of Public Health, and the World Health Organization
- How every screening technology is evaluated on a 0-to-15 composite score across sensitivity, specificity, evidence quality, burden, and clinical utility before entering the program
- How the three pillars of the platform (risk modeling, protocol optimization, and signal governance) function as one continuous loop
- How all clinically indicated testing is included in the member’s program, with no fragmented coordination left to the patient
Download the overview to see the clinical and scientific foundation behind the PreOncology Platform.
